COMBIPHAR
Megasari Utami has a diverse work experience spanning various roles in different companies. megasari began their career in 2004 as an Analyst in the Analytical Lab at PT Indospec Prima. From 2005 to 2006, they worked as a Lab Technical Support in the laboratory of PT Bintang Duta, where they conducted analyses for various samples. In 2006, they joined PT Pharos Indonesia as a Regulatory Affairs Supervisor, where they handled tasks such as patent assessment, clinical data studies assessment, and dossier checking. megasari then moved to MAHAKAM Group in 2014 as an R&D-Regulatory Affairs Assistant Manager, responsible for managing the regulatory team and overseeing registrations and variations for drugs, medical devices, cosmetics, and household products. In 2016, Megasari joined COMBIPHAR as a Regulatory International Market Manager, a role they held until 2018. megasari was later promoted to Senior Regulatory International Market Manager, and in January 2021, they became the Head of Regulatory Affairs for the Combiphar Group. Throughout their career, Megasari has demonstrated expertise in handling regulatory affairs for international markets and has executed pre-market approvals, product registrations, pharmacovigilance activities, advertising, and licensing for importers and distributors.
Megasari Utami completed their Bachelor's degree in Chemistry from Undip, where they studied from 1998 to 2003. megasari has also obtained the Lean Six Sigma Fundamentals certification from LinkedIn in October 2016.
This person is not in any teams
This person is not in any offices
COMBIPHAR
1 followers
Combiphar was founded in 1971 as a pharmaceutical company. Today, Combiphar is transforming into a modern consumer healthcare company that produces and markets more than 200 prescription and over-the-counter quality and affordable products, among others, OBH Combi cough syrup, Insto eye-care solution, JointFit gel-based relief for joints, CombiKid vitamin supplements, Privé green-tea based feminine hygiene wash, and Hezandra hepatoprotector supplement. Equipped with the latest production technology and the most up-to-date professional operation standards, Combiphar’s manufacturing plant, which is located in Padalarang, West Java, has most recently obtained the Therapeutic Goods Administration (TGA) Certification, allowing selected products to be exported to Australia. Additionally, Combiphar also has its own Research & Development facility, focusing on the quality optimization of prescription drugs to ensure that they meet the requirements of Bioavailability and Bioequivalence, as well as in the field of Nanotechnology. Combiphar has recently been ranked 2nd among local pharmaceutical companies recognized as “Indonesia’s Most Reputable Healthcare Brands 2015” (Onbee Research/SWA, May 2015) in terms of brand equity, customer loyalty, and customer experience.